ING/WellPoint and Aetna may or may not be talking, but several Aetna shareholders definitely want them to. Following Aetna’s rejection of their bid, which analysts valued at close to $70 a share, Aetna announced that it intended to split into two companies. Its shares have since fallen to the low $50s, which is at least better that its eight-year low of $38.50 a share reached in February. The complaining shareholders thought the takeover rejection was an error and have filed suit against Aetna in a Connecticut Superior Court alleging that it refused to adequately consider the ING/WellPoint bid simply to protect current management.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Insurer Rolls Out Policy to Protect Data Centers Against Growing Backlash 
Alabama Pharmacy, Not Agent, at Fault for Not Reading Policy Before $5M Judgment 
Fisherman Killed by 12-Foot Alligator at Central Florida Lake 
How One Hacker Used AI Agents, a Few Thousand Dollars to Break Into Websites From This Issue
